Injectable gel for first heart attacks treated with stents
Part of Heart & circulation clinical trials.
This trial tests a new gel that is injected into the heart during a stent procedure for a heart attack. The gel is designed to help the heart recover from the damage caused by the attack and may improve healing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- This is your first heart attack, and it affected the front wall of your heart.
- You received a stent within 12 hours of your symptoms starting.
- The main artery on the front of your heart was completely blocked before the stent was placed and opened successfully.
- You have no history of heart attacks, previous stent surgery, or bypass surgery.
- You do not have severe heart failure, kidney problems, or certain other serious health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a non-invasive method to improve blood flow in the arm during a heart attack. It may help reduce heart muscle damage before the standard artery-opening procedure.
This study tests different ways of restoring blood flow for people having a heart attack (STEMI) when the usual emergency procedure (primary PCI) may be delayed. It aims to see if giving a clot-busting medicine beforehand is as good as waiting for the procedure, or if another approach works better.
This trial studies whether a specific stent (with no polymer coating) plus a single blood thinner plan with aspirin and another P2Y12 medicine is as safe and effective as the standard two-medicine plan after a STEMI heart attack. It may help people avoid longer exposure to stronger blood-thinning if the new approach works as well.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
This trial tests a new way to treat heart attacks by using a special balloon to deliver medication to the heart's small blood vessels during a standard stenting procedure. It may help reduce damage to the heart muscle after a heart attack.
This study tests an investigational drug called SGC001 for people having a heart attack affecting the front wall of the heart. The goal is to see if adding this drug to the standard artery-opening procedure helps improve outcomes.
Hear when a new STEMI - ST Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.